CHI3L1 and Alzheimer disease: First, since the sample size regarding peripheral blood in the studies ultimately included in this meta-analysis was limited, additional clinical studies containing larger sample sizes are necessary to validate the effect of peripheral blood levels of YKL-40 in AD.